[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [$actu](/topic/$actu) ### Sentiment: XXX%  [Sentiment 24-Hour Time-Series Raw Data](/topic/$actu/time-series/sentiment.tsv) **Current Value**: XXX% **Daily Average**: XX% **1 Week**: XX% no change **1 Month**: XX% -XX% **1-Year High**: XXX% on 2025-05-16 **1-Year Low**: XX% on 2025-08-29 **Most Supportive Themes** - **Breakthrough Cancer Treatment:** (45%) Actuate Therapeutics is developing innovative cancer therapies, with elraglusib showing promising results in pancreatic cancer, potentially doubling survival rates and enhancing treatment response. - **Partnerships and Collaborations:** (25%) Actuate Therapeutics has established key partnerships with institutions like Harvard Medical School and Mass General Brigham, bolstering its clinical and regulatory momentum. **Most Critical Themes** - **Public Offering and Price Decline:** (30%) Actuate Therapeutics stock has declined following a public offering, creating negative sentiment among investors. Network engagement breakdown: | Network | Positive | % | Neutral | % | Negative | % | | ------- | -------- | - | ------- | - | -------- | - | | X | X | X% | XX | XX% | X | X% | | | | | | | | | | Total | X | X% | XX | XX% | X | X% |
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
1 Week: XX% no change
1 Month: XX% -XX%
1-Year High: XXX% on 2025-05-16
1-Year Low: XX% on 2025-08-29
Most Supportive Themes
Most Critical Themes
Network engagement breakdown:
Network | Positive | % | Neutral | % | Negative | % |
---|---|---|---|---|---|---|
X | X | X% | XX | XX% | X | X% |
Total | X | X% | XX | XX% | X | X% |
/topic/$actu/sentiment